Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the ...

An existing drug has shown it can significantly improve the quality of sleep for those suffering from obstructive sleep apnea (OSA), so much so that many trial participants were able to hang up their ...

A reduction in prescriptions of sleep drugs for older adults is associated with substantial health and economic benefits, according to an October study published in The Lancet Regional Health – ...

Millions of older Americans suffering from insomnia regularly use prescription sleep medications, despite the risk of serious side effects-such as falls, broken bones, cognitive impairment and ...

A new drug appears to reverse the fuzzy thinking caused by a lack of sleep. Studies in monkeys and people show that the drug restores the ability to perform complex mental tasks. The research is being ...

LONDON, Aug 29 (Reuters) - Generic competition to top-seller Ambien is eroding the multibillion-dollar sleeping pill market, but drug companies hope to revive growth with new medicines that work in ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...